“President Donald Trump is poised to nominate Stephen Hahn as the next commissioner of the FDA, according to BioCentury. Hahn, a radiation oncologist, is chief medical executive of the MD Anderson Cancer Center and reportedly the preferred pick of Department of Health and Human Services (HHS) Secretary Alex Azar.”
“Multiple reports have now identified Hahn as the most likely person to replace Scott Gottlieb as the next permanent commissioner of the FDA. Early last month, Politico Pro named Hahn as the “clear frontrunner,” adding that he was the only one of the three finalists to meet with Trump in person. The BioCentury report and a subsequent article in Stat also said Hahn is set to get the nomination.”
“All the reports note that Hahn still needs to complete background checks. If Hahn passes the checks, Trump will nominate him as FDA commissioner and the Senate confirmation process will begin.”
“Hahn’s background differs from those of his predecessors…” Read the full article here.
Source: Trump set to pick MD Anderson’s Hahn as FDA chief: reports – By Nick Paul Taylor, October 2, 2019. Fierce Biotech.
